September 22, 2017 Acad, Gov/Utilities Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10 PR/Corporate

Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx SANTA CLARA, Calif., September 22, 2017 Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug... Read more

September 21, 2017 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10

State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing

New Facility Helps Scientists Advance Translational Medical Research WHAT:              PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of the Translational Medical Engineering Demonstration Laboratory at a ceremony on September 19.  Co-founded with the State Key Laboratory of Biochemical Engineering, this facility will serve as a center for... Read more

September 21, 2017 Clinical Research/Diagn. M&A, Partnerships

Hitachi High-Technologies Enters the Cancer Diagnostic Testing Service Business through Capital Participation in U.S. Company MagArray, Inc.

Tokyo, Japan, September 21, 2017—Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that it would enter the diagnostic testing service business by accepting a private placement of new shares by MagArray, Inc. (MagArray) of the U.S. to make it an equity-method affiliate. Hitachi High-Tech has made the field of biotechnology and healthcare its priority.... Read more

September 19, 2017 Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Announces Expanded Use of Cancer Diagnostic in the United States

Dako PD-L1 IHC 28-8 PharmDx Approved for Two New Indications SANTA CLARA, Calif., September 19, 2017 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma... Read more

September 15, 2017 Clinical Research/Diagn. Microscopy

TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) partial clinical hold reactive statement

Basel, 15 September 2017 TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) partial clinical hold reactive statement Roche (SIX: RO, ROG; OTCQX: RHHBY): Based on emerging safety data from clinical trials evaluating pembrolizumab in combination with either lenalidomide or pomalidomide in multiple myeloma, the FDA has requested that a Phase Ib and a Phase Ib/II TECENTRIQ study... Read more

September 14, 2017 Clinical Research/Diagn. Life Science Tools

Perkinelmer And In-Depth Genomics Team Up For Whole Genome Sequencing Diagnostic Program For Rare Diseases

In-Depth Genomics Leverages PerkinElmer’s Comprehensive Sequencing Services to Provide Whole Genome Sequencing to Neurology Patients National Society of Genetic Counselors Annual Conference, Columbus, Ohio, Booth #535 –September 14, 2017 –PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced an innovative collaboration with In-Depth Genomics (IDG) to support IDG’s Whole Genome... Read more

September 13, 2017 Clinical Research/Diagn. M&A, Partnerships

Fabric Genomics and Genome Medical Partner to Help Patients and Clinicians Better Understand Genetic Results

September 13, 2017 06:00 AM Pacific Daylight Time OAKLAND, Calif. & SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing... Read more

September 11, 2017 Clinical Research/Diagn. PR/Corporate

Wageningen University and Research iGEM 2017

Wageningen University (Netherlands) and Research 2017 iGEM Team participate in the iGEM competition, which is a global competition to tackle real-world problems using synthetic biology. The iGEM competition builds up to the Giant Jamboree at MIT in Boston, where all teams come together to present their project. This year Hamilton Bonaduz AG  sponsor our project!... Read more